Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow-Reference-Cited by-同舟云学术

Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow

Published:2018-02-01 Issue:5 Volume:131 Page:577-581
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Lazarevic Vladimir¹,Orsmark-Pietras Christina²,Lilljebjörn Henrik²,Pettersson Louise³⁴,Rissler Marianne²,Lübking Anna¹,Ehinger Mats⁴,Juliusson Gunnar¹⁵,Fioretos Thoas²

Affiliation:

1. Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden;

2. Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden;

3. Department of Pathology, Hallands Hospital, Halmstad, Sweden;

4. Department of Oncology and Pathology, Skåne University Hospital, Lund, Sweden; and

5. Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/5/577/1465744/blood793620.pdf

Reference21 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients;Pileri;Leukemia,2007

3. Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980-2008;Ganzel;J Clin Oncol,2016

4. Granulocytic sarcoma: a systematic review;Yilmaz;Am J Blood Res,2013

5. Acute myeloid leukemia in the real world: why population-based registries are needed;Juliusson;Blood,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-126 as a Biomarker for Cancer Stem Cells: Role in Chemotherapy Resistance in Iraqi Patients with Acute Myeloid Leukemia;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-02-29

2. An Enhancer LncRNA Regulates NFE2 Expression and Proliferation in Human Leukemic K562 Cells*;PROG BIOCHEM BIOPHYS;2024

3. Myeloid sarcoma: An overview;Seminars in Diagnostic Pathology;2023-05

4. The SIRT2 Pathway Is Involved in the Antiproliferative Effect of Flavanones in Human Leukemia Monocytic THP-1 Cells;Biomedicines;2022-09-24

5. In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported;Blood Advances;2021-12-03